Lupin Ltd is hosting a walk-in drive on Friday, May 2nd, 2025, at our manufacturing facility located in Tarapur. We are seeking candidates for various positions within the Production, Finance, Mechanical & Utility, and Instrumentation departments. Applicants should possess qualifications such as B.Sc., M.Sc., B.E., Diploma, or CMA, and we have openings for designations including Associate, Officer, Senior Officer, and Executive. Ideal candidates will have between 2 to 6 years of relevant experience. The walk-in interviews will take place at Lupin Ltd, Tarapur, situated at T-142 MIDC Industrial Area, Tarapur Via Boisar, Tarapur-401506, starting at 9:30 AM.
Vacancy details
Department: Production / Mechanical & Utility / Finance / Instrumentation
Role: Associate/ Officer/ Sr. Officer/ Executive
Qualification: Diploma /B.Sc./ M.Sc. / B.E / CMA
Experience required: 02 to 06 yrs. of relevant experience
Walk-In Interview Details:
Date of interview: 2nd May 2025 (Friday)
Venue: Lupin Limited, T-142, MIDC Industrial Area, Tarapur via Boisar, Tarapur, Maharashtra – 401506.
Note: Please note that candidates must have achieved a first-class degree with a minimum of 60% marks, or possess five years of experience if holding a second-class degree.
Contact Information:
For any inquiries or to submit your profiles, please contact us via email at gaurangikudavkar@lupin.com or prachipatil@lupin.com, or reach out to us at 7391040115.
Documents to Carry
To participate in the interview, please bring several important documents, including your most recent resume, offer and increment letters, the last three months of pay slips and bank statements, service letters from previous employers, all educational certificates, as well as your Aadhar and PAN cards.
About Lupin Limited
Lupin Limited is an Indian multinational pharmaceutical company headquartered in Mumbai and is a significant player in the global generic pharmaceutical market. It has a U.S. subsidiary and has expanded its portfolio, acquiring brands like ONDERO® and ONDERO MET® to grow its presence in the diabetes treatment sector. As one of the largest generic pharmaceutical companies by revenue, Lupin Limited demonstrates a considerable market influence.